Purpose Maternal intravenous fluid administration during labor is widely used for treatment administration and to ensure adequate uteroplacental perfusion. Its potential effects on neonatal outcomes, particularly early weight loss, are not fully understood, with data mainly derived from breastfed infants. Evidence in formula-fed infants remains lacking. We aimed to evaluate the impact of prepartum maternal fluid administration on 48-hour weight loss in exclusively formula-fed newborns. Blood cord haematocrit was also studied as a reflect of neonatal potential blood dilution. Methods This retrospective, observational study was conducted at Amiens-Picardie University Hospital between September and December 2024. Term singleton infants exclusively formula-fed during the first two days of life were included. Maternal intravenous fluid volumes during the 12 hours preceding delivery were recorded. Primary outcome was neonatal weight loss at day 2. The secondary outcome was blood cord hematocrit. Results Among 200 mother-infant dyads, maternal fluid loading > 4 mL/kg in the 4–6 hours before delivery was significantly associated with greater neonatal weight loss at 48 hours (p = 0.0168 and p = 0.027, respectively). Oxytocin exposure was also associated with an increased weight loss (p = 0.036). Higher fluid intake > 2 mL/kg in the 2 hours before delivery correlated with lower cord haematocrit (p = 0.024). Conclusion A higher maternal intrapartum fluid administration was associated with an increased neonatal weight loss and a lower blood cord hematocrit in formula-fed infants. These findings support the hypothesis of transient neonatal fluid overload followed by diuresis, and underline the need to account for maternal fluid balance when interpreting early neonatal weight changes.
Alcohol is a major cause of hepatocellular carcinoma (HCC), accounting for 30
New-onset atrial fibrillation (NOAF) frequently complicates septic shock and is associated with haemodynamic instability, prolonged intensive care unit stay, and increased mortality. Despite its clinical relevance, guidance on heart rate (HR) management remains limited, particularly regarding the use of ultra-short-acting β₁-blockers. To reduce variability in clinical practice, a European multidisciplinary panel developed a consensus on the management of atrial fibrillation in septic shock, with a focus on landiolol. A modified RAND/UCLA Delphi methodology was applied. Nine European experts in intensive care, anaesthesiology, and cardiology participated in two Delphi rounds. Fifty-five statements across nine thematic areas were evaluated using a 9-point Likert scale. Consensus was predefined as ≥ 80
BACKGROUND AND HYPOTHESIS:The anticholinergic burden is the cumulative effect of drugs with anticholinergic properties and is typically measured using one of several anticholinergic scales. We hypothesised that these scales may not fully capture all the relevant adverse drug reactions (ADRs). By accessing the French national pharmacovigilance database (FPVD) and focusing on drug classes known to induce anticholinergic ADRs, the objectives of the present study were to describe the reported ADRs, characterise the drugs involved, and examine the drugs' classification within anticholinergic scales. METHODS:Cases were extracted from the FPVD (1985-2024) when the suspected drug (i) had a high anticholinergic score, according to one or more of 22 anticholinergic burden scales, or (ii) belonged to the same class as the drug identified in (i). The anticholinergic ADRs investigated were confusion, glaucoma, tachycardia, urinary retention, constipation, intestinal obstruction and mydriasis. RESULTS:Of the 101,365 cases reported in the FPVD, regarding the selected drugs, 9629 (9.5%) involved at least one anticholinergic ADR investigated. Patients who experienced at least one anticholinergic ADR had a median age of 61 years (interquartile range: 38-79), and the majority were women (58%). Confusion was the most frequently reported anticholinergic ADR (4603 cases, of which 81% were classified as serious), followed by tachycardia (n = 1541 cases, 70% serious), and urinary retention (1061 cases, 75% serious). It is noteworthy that 98% of the 561 reported cases of intestinal obstruction were classified as serious. The drug classes with the highest number of reports were (by far) anxiolytics, antidepressants, and antipsychotics. Some drugs linked to anticholinergic ADRs in the FPVD were not present in (or were assigned a low score by) commonly used anticholinergic scales, such as the Anticholinergic Cognitive Burden. CONCLUSIONS:Anticholinergic ADRs affect both older and younger adults. The existing scoring systems might not fully capture the range of medications involved in real-world anticholinergic-related events.
BK polyomavirus (BKPyV) persists in the renourinary tract of most adults and can replicate under immunosuppression. In kidney transplant recipients (KTR), it may cause BKPyV-associated nephropathy (BKPyVAN), while in hematopoietic stem cell transplant recipients (HSCT), it is more often linked to hemorrhagic cystitis (HC). These clinical differences are generally attributed to the type of graft and immunosuppressive regimen. However, viral factors such as genotype or mutations might also influence tissue tropism and pathogenesis. This study aimed to compare the virological features of BKPyV between KTR and HSCT recipients and to explore possible associations with clinical manifestations. This retrospective study included 101 transplanted patients (66 KTR, 35 HSCT) at Amiens-Picardie University Hospital (France) between 2019 and 2023, with at least one episode of BKPyV DNAuria during post-allograft follow-up. Viral genotyping was performed by Sanger sequencing, while NGS (Next-generation Sequencing) provided complete coding genome sequences for 51 patients. Genotype distribution was similar in both groups, with Ib2 as the most frequent subtype. No genotype or mutation was associated with a specific graft type or complication, except for the small t antigen gene, which appeared to be more frequently mutated in KTRs. Viral replication occurred earlier and at higher levels in HSCT patients (mean peak DNAuria: 9.3 log10 vs 7.4 log10 copies/mL in KTR; p < 0.0001). In KTRs, patients with presumptive BKPyVAN were significantly older than those with asymptomatic replication. These findings suggest that viral genetic determinants play a lesser role in BKPyV replication and its clinical consequences compared to host-related factors.